Impacted Medications:
- Bydureon
- Byetta
- Mounjaro
- Ozempic
- Rybelsus
- Saxenda
- Soliqua
- Trulicity
- Victoza
- Wegovy
- Zepbound
Your BILH health plan administered by InscriptRx has adopted unique coverage criteria for glucagon-like peptide-1 (GLP-1) medications. Plan members using GLP-1s for weight loss specifically are required to complete a Medication Therapy Management (MTM) virtual visit with the BILH Weight Loss Management Clinic.
To assist with this process, the BILH Weight Management Team will call to schedule an appointment or they can be reached at 781-352-6551 to answer questions or to proactively schedule your visit.
What to expect during an MTM appointment: A weight loss-specialized pharmacist will assess and evaluate your clinical condition, review any side effects, answer any questions you have about your medications, and discuss lifestyle modifications to enhance your outcomes.
For all indications for GLP-1s, please use this form to submit a prior authorization for the product.